Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
2-naphthylamine | [no description available] | medium | 37 | 0 | naphthylamine | carcinogenic agent |
chlorophyll a | [no description available] | medium | 1 | 0 | chlorophyll; methyl ester | cofactor |
microcystin | [no description available] | medium | 1 | 0 | peptide | |
copper sulfate | [no description available] | medium | 1 | 0 | metal sulfate | emetic; fertilizer; sensitiser |
mocetinostat | [no description available] | medium | 1 | 0 | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent |
malondialdehyde | [no description available] | medium | 1 | 0 | dialdehyde | biomarker |
phthalic acid | [no description available] | medium | 1 | 0 | benzenedicarboxylic acid | human xenobiotic metabolite |
prometryne | [no description available] | medium | 1 | 0 | diamino-1,3,5-triazine; methylthio-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
lysine | [no description available] | medium | 1 | 0 | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
phenylalanine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
isoprene | [no description available] | medium | 5 | 0 | alkadiene; hemiterpene; volatile organic compound | plant metabolite |
1-naphthylphenylamine | [no description available] | medium | 2 | 0 | naphthalenes | |
1-naphthylamine | [no description available] | medium | 3 | 0 | naphthylamine | human xenobiotic metabolite |
n-isopropyl-n-phenyl-4-phenylenediamine | [no description available] | medium | 4 | 0 | | |
n-(1,3-dimethylbutyl)-n'-phenyl-1,4-phenylenediamine | [no description available] | medium | 1 | 0 | | |
tri-o-cresyl phosphate | [no description available] | medium | 1 | 0 | | |
c.i. 42510 | [no description available] | medium | 1 | 0 | | |
n,n'-diphenyl-4-phenylenediamine | [no description available] | medium | 1 | 0 | N-substituted diamine; secondary amino compound | antioxidant |
3-methylcholanthrene | [no description available] | medium | 1 | 0 | ortho- and peri-fused polycyclic arene | aryl hydrocarbon receptor agonist; carcinogenic agent |
phenobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
benzo(a)pyrene | [no description available] | medium | 1 | 0 | ortho- and peri-fused polycyclic arene | carcinogenic agent; mouse metabolite |
delphinidin | [no description available] | medium | 1 | 0 | anthocyanidin chloride | |
formaldehyde | [no description available] | medium | 2 | 0 | aldehyde; one-carbon compound | allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
sulfur | [no description available] | medium | 1 | 0 | chalcogen; nonmetal atom | macronutrient |
ethanolamine | [no description available] | medium | 2 | 0 | ethanolamines; primary alcohol; primary amine | Escherichia coli metabolite; human metabolite; mouse metabolite |
benzidine | [no description available] | medium | 1 | 0 | biphenyls; substituted aniline | carcinogenic agent |
dimethyl sulfoxide | [no description available] | medium | 1 | 0 | sulfoxide; volatile organic compound | alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger |
triethanolamine | [no description available] | medium | 1 | 0 | amino alcohol; tertiary amino compound; triol | buffer; surfactant |
lead | [no description available] | medium | 1 | 0 | carbon group element atom; elemental lead; metal atom | neurotoxin |
acrylonitrile | [no description available] | medium | 1 | 0 | aliphatic nitrile; volatile organic compound | antifungal agent; carcinogenic agent; fungal metabolite; mutagen; polar aprotic solvent |
vinyl chloride | [no description available] | medium | 1 | 0 | chloroethenes; gas molecular entity; monohaloethene | carcinogenic agent |
chromium | [no description available] | medium | 1 | 0 | chromium group element atom; metal allergen | micronutrient |
uracil | [no description available] | medium | 1 | 0 | pyrimidine nucleobase; pyrimidone | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite |
naphthalene | [no description available] | low | 0 | 0 | naphthalenes; ortho-fused bicyclic arene | apoptosis inhibitor; carcinogenic agent; environmental contaminant; mouse metabolite; plant metabolite; volatile oil component |
2-(6-methoxy-2-naphthalenyl)propanoic acid | [no description available] | low | 0 | 0 | naphthalenes | |
N-(2-aminoethyl)-5-chloro-1-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
butenafine | [no description available] | low | 0 | 0 | naphthalenes; tertiary amine | antifungal drug; EC 1.14.13.132 (squalene monooxygenase) inhibitor |
hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester | [no description available] | low | 0 | 0 | acetate ester; naphthalenes; organic phosphonate | tyrosine kinase inhibitor |
1-(2-naphthalenyl)-3-[(phenylmethyl)-propan-2-ylamino]-1-propanone | [no description available] | low | 0 | 0 | naphthalenes | |
1-(2-naphthalenyl)-2-propen-1-one | [no description available] | low | 0 | 0 | naphthalenes | |
ml 9 | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
w 12 | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; organochlorine compound; primary amino compound; sulfonamide | |
n-(6-aminohexyl)-1-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
nafoxidine | [no description available] | low | 0 | 0 | benzenes; naphthalenes; ring assembly | |
nafronyl | [no description available] | low | 0 | 0 | naphthalenes | |
naphazoline | [no description available] | low | 0 | 0 | naphthalenes | |
pronethalol | [no description available] | low | 0 | 0 | naphthalenes | |
propranolol | [no description available] | low | 0 | 0 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
sc-10 | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
N,6,6-trimethyl-N-(1-naphthalenylmethyl)-1-hept-2-en-4-ynamine | [no description available] | low | 0 | 0 | naphthalenes | |
carbaryl | [no description available] | low | 0 | 0 | carbamate ester; naphthalenes | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant growth retardant |
naphthaleneacetamide | [no description available] | low | 0 | 0 | naphthalenes; primary carboxamide | synthetic auxin |
2-naphthalenethiol | [no description available] | low | 0 | 0 | naphthalenes | |
2-methoxynaphthalene | [no description available] | low | 0 | 0 | naphthalenes | |
bromelia | [no description available] | low | 0 | 0 | naphthalenes | |
benzo(j)fluoranthene | [no description available] | low | 0 | 0 | naphthalenes | |
benzo(k)fluoranthene | [no description available] | low | 0 | 0 | naphthalenes | |
chlornaphazin | [no description available] | low | 0 | 0 | naphthalenes | |
methallenestril | [no description available] | low | 0 | 0 | naphthalenes | |
1,5-naphthylene di-isocyanate | [no description available] | low | 0 | 0 | naphthalenes | |
nitrosocarbaryl | [no description available] | low | 0 | 0 | carbamate ester; naphthalenes; nitroso compound | carcinogenic agent; mutagen |
devrinol | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid amide; naphthalenes | |
2,6-diisopropylnaphthalene | [no description available] | low | 0 | 0 | naphthalenes | agrochemical; plant growth retardant |
nadoxolol | [no description available] | low | 0 | 0 | naphthalenes | |
naftifine | [no description available] | low | 0 | 0 | allylamine antifungal drug; naphthalenes; tertiary amine | EC 1.14.13.132 (squalene monooxygenase) inhibitor; sterol biosynthesis inhibitor |
tolrestat | [no description available] | low | 0 | 0 | naphthalenes | EC 1.1.1.21 (aldehyde reductase) inhibitor |
lonapalene | [no description available] | low | 0 | 0 | naphthalenes; organochlorine compound | |
fananserin | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
aptiganel | [no description available] | low | 0 | 0 | naphthalenes | |
5-Aminoacenaphthene | [no description available] | low | 0 | 0 | naphthalenes | |
dapoxetine | [no description available] | low | 0 | 0 | naphthalenes | |
2-naphthyl sulfate | [no description available] | low | 0 | 0 | aryl sulfate; naphthalenes | |
bexarotene | [no description available] | low | 0 | 0 | benzoic acids; naphthalenes; retinoid | antineoplastic agent |
1,8-bis(dimethylamino)naphthalene | [no description available] | low | 0 | 0 | naphthalenes | |
1-(1,2-dihydroacenaphthylen-5-yl)ethanone | [no description available] | low | 0 | 0 | naphthalenes | |
1,1,6-trimethyl-1,2-dihydronaphthalene | [no description available] | low | 0 | 0 | naphthalenes | |
11-(dansylamino)undecanoic acid | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
n-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
xaliproden hydrochloride | [no description available] | low | 0 | 0 | naphthalenes | |
xaliproden | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; naphthalenes; tertiary amino compound; tetrahydropyridine | serotonergic agonist |
1-naphthylacetylspermine | [no description available] | low | 0 | 0 | naphthalenes | |
cinacalcet | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; naphthalenes; secondary amino compound | calcimimetic; P450 inhibitor |
birb 796 | [no description available] | low | 0 | 0 | aromatic ether; morpholines; naphthalenes; pyrazoles; ureas | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; immunomodulator |
5-(2-naphthalenylmethylidene)-1,3-diazinane-2,4,6-trione | [no description available] | low | 0 | 0 | naphthalenes | |
6,11-dioxo-12-naphtho[2,3-b]indolizinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
acetic acid (4-acetyloxy-6,7-dimethyl-5,8-dihydronaphthalen-1-yl) ester | [no description available] | low | 0 | 0 | naphthalenes | |
korupensamine-b | [no description available] | low | 0 | 0 | isoquinolines; naphthalenes | |
dioncophylline a | [no description available] | low | 0 | 0 | biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes; naphthalenes | antifungal agent; antimalarial; metabolite; molluscicide |
1-[(4-fluoro-1-naphthalenyl)sulfonyl]piperidine | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
6-tert-butylnaphthalene-2,3-dicarbonitrile | [no description available] | low | 0 | 0 | naphthalenes | |
5-(diethylsulfamoyl)-3-hydroxy-2-naphthalenecarboxylic acid | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
2,6-dimethyl-4-[1-(2-naphthalenylsulfonyl)-4-piperidinyl]morpholine | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
1,3-dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione | [no description available] | low | 0 | 0 | naphthalenes | |
5-(4-methyl-1-piperidinyl)-2-(1-naphthalenylmethyl)-4-oxazolecarbonitrile | [no description available] | low | 0 | 0 | naphthalenes | |
5-[2-(3,4-dimethoxyphenyl)ethylamino]-2-(1-naphthalenylmethyl)-4-oxazolecarbonitrile | [no description available] | low | 0 | 0 | naphthalenes | |
3-methyl-6-(1-naphthalenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole | [no description available] | low | 0 | 0 | naphthalenes; triazolothiadiazole | |
N-(1,2-dihydroacenaphthylen-5-yl)methanesulfonamide | [no description available] | low | 0 | 0 | naphthalenes | |
N,N-diethyl-2-oxo-1H-benzo[cd]indole-6-sulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
spiro[1,3-dihydroperimidine-2,1'-cycloheptane] | [no description available] | low | 0 | 0 | naphthalenes | |
2-(3-nitrophenyl)-2,3-dihydro-1H-perimidine | [no description available] | low | 0 | 0 | naphthalenes | |
2-phenylmethoxy-1-naphthalenecarboxaldehyde | [no description available] | low | 0 | 0 | naphthalenes | |
alpha-naphthyl thiourea | [no description available] | low | 0 | 0 | naphthalenes | |
4-[(2-methoxy-1-naphthalenyl)methyl]thiomorpholine | [no description available] | low | 0 | 0 | naphthalenes | |
N-(3-methoxyphenyl)-2-benzo[cd]indolamine | [no description available] | low | 0 | 0 | naphthalenes | |
LSM-21110 | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
4-[(6-methoxy-2-naphthalenyl)sulfonyl]morpholine | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
LSM-28278 | [no description available] | low | 0 | 0 | naphthalenes | |
4-(2-naphthalenylmethyl)-1-piperazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
6-(4-morpholinyl)naphthalene-2,3-dicarbonitrile | [no description available] | low | 0 | 0 | naphthalenes | |
N-(1-naphthalenyl)-4-(phenylmethyl)-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
3,5-dimethyl-1-[(7-methyl-2-naphthalenyl)sulfonyl]pyrazole | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
2-methyl-N-(2-naphthalenyl)-3-furancarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
4-chloro-N-(2-pyridinyl)-1-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
3-(2-benzo[cd]indolylamino)benzoic acid | [no description available] | low | 0 | 0 | naphthalenes | |
4-(2-naphthalenyloxymethyl)-2-thiazolamine | [no description available] | low | 0 | 0 | naphthalenes | |
1-(1-naphthalenylmethoxy)benzotriazole | [no description available] | low | 0 | 0 | naphthalenes | |
3-chloro-4,5-dimethoxy-N-(1-naphthalenylmethyl)benzamide | [no description available] | low | 0 | 0 | naphthalenes | |
1-[[2-(4-chlorophenyl)-1-oxoethyl]amino]-3-(1-naphthalenyl)urea | [no description available] | low | 0 | 0 | naphthalenes | |
1-methyl-N-(2-naphthalenyl)-5-benzotriazolecarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
N-(1-naphthalenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine | [no description available] | low | 0 | 0 | naphthalenes | |
1-methyl-2-oxo-N-(2-pyridinyl)-6-benzo[cd]indolesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
pyrabactin | [no description available] | low | 0 | 0 | naphthalenes; organobromine compound; pyridines; sulfonamide | abscisic acid receptor agonist; hormone; plant growth regulator |
1-ethyl-2-oxo-N-(2-pyridinylmethyl)-6-benzo[cd]indolesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
N-[(1,2-dihydroacenaphthylen-5-ylamino)-sulfanylidenemethyl]-2-phenoxyacetamide | [no description available] | low | 0 | 0 | naphthalenes | |
1-(4-bromophenyl)-4-[1-naphthalenyl(oxo)methyl]-3-pyrazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | carbonyl compound; naphthalenes | |
1-(1,2,3-benzothiadiazol-5-yl)-3-(1-naphthalenyl)urea | [no description available] | low | 0 | 0 | naphthalenes | |
1-(4-methylphenyl)sulfonyl-4-(2-naphthalenylsulfonyl)-1,4-diazepane | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
N2,N2-dimethyl-6-[[[1-(1-naphthalenyl)-5-tetrazolyl]thio]methyl]-1,3,5-triazine-2,4-diamine | [no description available] | low | 0 | 0 | naphthalenes | |
terbinafine | [no description available] | low | 0 | 0 | acetylenic compound; allylamine antifungal drug; enyne; naphthalenes; tertiary amine | EC 1.14.13.132 (squalene monooxygenase) inhibitor; P450 inhibitor; sterol biosynthesis inhibitor |
1-ethyl-N-[3-(4-morpholinyl)propyl]-2-oxo-6-benzo[cd]indolesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
N-[4-(4-morpholinyl)phenyl]-2-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
4-fluorobenzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
4-bromobenzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
2-benzofurancarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
N-(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-2-yl)-2-(2-naphthalenyloxy)acetamide | [no description available] | low | 0 | 0 | naphthalenes | |
thiocyanic acid [2-(1-naphthalenyl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | naphthalenes | |
2-[2-(1-naphthalenyloxy)ethylthio]pyrimidine | [no description available] | low | 0 | 0 | naphthalenes | |
N-[2-(1-naphthalenyl)-1,3-benzoxazol-5-yl]-1H-1,2,4-triazole-5-carboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
N-(2-naphthalenyl)-2-[[6-[[[2-(2-naphthalenylamino)-2-oxoethyl]thio]methyl]-2-pyridinyl]methylthio]acetamide | [no description available] | low | 0 | 0 | naphthalenes | |
1-(1-naphthalenylmethyl)-3-phenylurea | [no description available] | low | 0 | 0 | naphthalenes | |
N'-(3,4-dihydro-2H-pyrrol-5-yl)-2-(2-naphthalenylamino)acetohydrazide | [no description available] | low | 0 | 0 | naphthalenes | |
N-butyl-N-methyl-2-benzo[cd]indolamine | [no description available] | low | 0 | 0 | naphthalenes | |
N-(5-methyl-3-isoxazolyl)-2-(2-naphthalenylthio)acetamide | [no description available] | low | 0 | 0 | naphthalenes | |
LSM-19724 | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
N-(3-chloro-2-quinoxalinyl)-2-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
2-(2-naphthalenylsulfonylamino)acetic acid [2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
5-(1-naphthalenylamino)-3H-1,3,4-thiadiazole-2-thione | [no description available] | low | 0 | 0 | naphthalenes | |
4-(3,5-dichloro-4-pyridinyl)-N-(1-naphthalenyl)-1,4-diazepane-1-carboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
2-(1-naphthalenyl)-N-[2,2,2-trichloro-1-[[(2-chloroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide | [no description available] | low | 0 | 0 | naphthalenes | |
acetic acid [4-[acetyl-(4-chlorophenyl)sulfonylamino]-1-naphthalenyl] ester | [no description available] | low | 0 | 0 | naphthalenes | |
2,2-dibromo-1-methyl-N-(2-naphthalenyl)-1-cyclopropanecarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
N'-[2-(1-naphthalenyloxy)-1-oxoethyl]-2-oxolanecarbohydrazide | [no description available] | low | 0 | 0 | naphthalenes | |
N-[3-(3,5-dimethyl-1-pyrazolyl)-2-hydroxypropyl]-N-(4-methylphenyl)-2-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
1-[2-furanyl(oxo)methyl]-6-(1-pyrrolidinylsulfonyl)-2-benzo[cd]indolone | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
2-(2-bromophenyl)-2,3-dihydro-1H-perimidine | [no description available] | low | 0 | 0 | naphthalenes | |
acetic acid [1-[(3-nitrophenyl)-(1-oxopentylamino)methyl]-2-naphthalenyl] ester | [no description available] | low | 0 | 0 | naphthalenes | |
4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]-2-butyn-1-ol | [no description available] | low | 0 | 0 | naphthalenes | |
N-(2-methoxyethyl)-1-methyl-2-oxo-6-benzo[cd]indolesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
3-(5-methyl-2-furanyl)-5-[1-(2-naphthalenylsulfonyl)-3-piperidinyl]-1,2,4-oxadiazole | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
(7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazol-3-yl)-(4-morpholinyl)methanone | [no description available] | low | 0 | 0 | naphthalenes | |
1-(1-naphthalenyl)-3-[3-(1-pyrrolidinyl)propyl]urea | [no description available] | low | 0 | 0 | naphthalenes | |
N-[3-(1-imidazolyl)propyl]-7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazole-3-carboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
7-methoxy-4,5-dihydro-2H-benzo[g]indazole-3-carboxylic acid | [no description available] | low | 0 | 0 | naphthalenes | |
(1R,2R)-2-[(R)-(diphenylphosphorylamino)-phenylmethyl]-N-(2-naphthalenyl)-1-cyclopropanecarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
5-methyl-N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-(2-naphthalenylamino)-1-oxopropan-2-yl]cyclopropyl]-phenylmethyl]-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
2,5-dimethyl-N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-(2-naphthalenylamino)-1-oxopropan-2-yl]cyclopropyl]-phenylmethyl]-3-pyrazolecarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
2-(1-naphthalenyl)acetic acid [2-[4-chloro-3-(dimethylsulfamoyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | naphthalenes | |
1,1-dimethyl-3-[3-(4-morpholinyl)propyl]-3-(1-naphthalenylmethyl)urea | [no description available] | low | 0 | 0 | naphthalenes | |
N-(4-ethoxyphenyl)sulfonyl-N-(2-oxo-5-benzo[g][1,3]benzoxathiolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-dimethoxyphosphoryl-2-(1-naphthalenyl)-5-oxazolamine | [no description available] | low | 0 | 0 | naphthalenes | |
4-[4-dimethoxyphosphoryl-2-(1-naphthalenyl)-5-oxazolyl]morpholine | [no description available] | low | 0 | 0 | naphthalenes | |
2-amino-1-(dimethylamino)-4-(1-naphthalenyl)-5-oxo-7-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile | [no description available] | low | 0 | 0 | naphthalenes; quinolines | |
4-[4-diethoxyphosphoryl-2-(1-naphthalenyl)-5-oxazolyl]morpholine | [no description available] | low | 0 | 0 | naphthalenes | |
2-[(1-methyl-2-imidazolyl)thio]-1-(2-naphthalenyl)ethanone | [no description available] | low | 0 | 0 | naphthalenes | |
2-(1-naphthalenyl)-4-quinolinecarboxylic acid [1-[(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)amino]-1-oxopropan-2-yl] ester | [no description available] | low | 0 | 0 | naphthalenes; quinolines | |
5-methyl-4-[(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)-[1-(1-naphthalenylmethyl)-3-indolyl]methyl]-1,2-dihydropyrazol-3-one | [no description available] | low | 0 | 0 | naphthalenes | |
N-(1-dibutoxyphosphoryl-4-oxo-1-naphthalenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes | |
4-dimethoxyphosphoryl-2-(1-naphthalenyl)-N-(phenylmethyl)-5-oxazolamine | [no description available] | low | 0 | 0 | naphthalenes | |
4-chlorobenzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
4-amino-5-cyano-2-(1-naphthalenylmethylthio)-3-azaspiro[5.5]undeca-2,4-diene-1-carboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
N-[[[2-(2-naphthalenyloxy)-1-oxopropyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
(4-chloro-1-ethyl-3-pyrazolyl)-[3-(2-hydroxyphenyl)-5-(2-naphthalenyl)-3,4-dihydropyrazol-2-yl]methanone | [no description available] | low | 0 | 0 | naphthalenes | |
N-(4-methoxyphenyl)sulfonyl-N-(2-oxo-5-benzo[g][1,3]benzoxathiolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | [no description available] | low | 0 | 0 | benzoic acids; naphthalenes; retinoid | antineoplastic agent; retinoic acid receptor agonist; teratogenic agent |
cgp 71683 a | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
bedaquiline | [no description available] | low | 0 | 0 | aromatic ether; naphthalenes; organobromine compound; quinolines; tertiary alcohol; tertiary amino compound | antitubercular agent; ATP synthase inhibitor |
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one | [no description available] | low | 0 | 0 | naphthalenes | |
2-methyl-5-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]-3-benzofurancarboxylic acid butyl ester | [no description available] | low | 0 | 0 | naphthalenes; sulfonic acid derivative | |
N'-(1-methyl-4-pyrazolo[3,4-d]pyrimidinyl)-2-(1-naphthalenyl)acetohydrazide | [no description available] | low | 0 | 0 | naphthalenes | |
1-(3-ethylphenyl)-3-(1-naphthalenyl)thiourea | [no description available] | low | 0 | 0 | naphthalenes | |
ws-5995 c | [no description available] | low | 0 | 0 | benzenes; naphthalenes; ring assembly | |
np 031112 | [no description available] | low | 0 | 0 | benzenes; naphthalenes; thiadiazolidine | anti-inflammatory agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent |
(6-methoxy-2-naphthalenyl)-[1-[(2-methyl-5-thiazolyl)methyl]-3-piperidinyl]methanone | [no description available] | low | 0 | 0 | naphthalenes | |
1,2-dihydroacenaphthylen-5-yl-[1-[(6-methyl-2-pyridinyl)methyl]-3-piperidinyl]methanone | [no description available] | low | 0 | 0 | naphthalenes | |
1,2-dihydroacenaphthylen-5-yl-[1-(2-pyridinylmethyl)-3-piperidinyl]methanone | [no description available] | low | 0 | 0 | naphthalenes | |
1-[3-[(6-methoxy-2-naphthalenyl)-oxomethyl]-1-piperidinyl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)thio]ethanone | [no description available] | low | 0 | 0 | naphthalenes | |
4-[[(4S)-2-amino-3-[2-(1-naphthalenyl)ethyl]-4,5-dihydroimidazol-4-yl]methyl]phenol | [no description available] | low | 0 | 0 | naphthalenes | |
[5-[(4-methoxy-1-naphthalenyl)oxymethyl]-3-isoxazolyl]-(4-methoxy-1-piperidinyl)methanone | [no description available] | low | 0 | 0 | naphthalenes | |
GRL-0617 | [no description available] | low | 0 | 0 | benzamides; naphthalenes; secondary carboxamide; substituted aniline | anticoronaviral agent; protease inhibitor |
N-(1-naphthalenylmethyl)-2-thiophenecarboxamide | [no description available] | low | 0 | 0 | naphthalenes | |
(1-(4-(naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine | [no description available] | low | 0 | 0 | naphthalenes | |
N-[4-cyano-2-(1-naphthalenyl)-5-oxazolyl]acetamide | [no description available] | low | 0 | 0 | naphthalenes | |
2-[(4-methylphenyl)methylthio]-5-(1-naphthalenyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | naphthalenes | |
5-amino-2-(1-naphthalenyl)-4-oxazolecarbonitrile | [no description available] | low | 0 | 0 | naphthalenes | |
4-(dimethylamino)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
1H-imidazole-5-carboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester | [no description available] | low | 0 | 0 | naphthalenes | |
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide | [no description available] | low | 0 | 0 | naphthalenes | |
KOM70144 | [no description available] | low | 0 | 0 | acetamides; benzamides; naphthalenes; secondary carboxamide | anticoronaviral agent; protease inhibitor |
lesinurad | [no description available] | low | 0 | 0 | aryl sulfide; cyclopropanes; monocarboxylic acid; naphthalenes; organobromine compound; triazoles | uricosuric drug |
difenacoum | [no description available] | low | 0 | 0 | benzenes; naphthalenes; ring assembly | |
bromfenacoum | [no description available] | low | 0 | 0 | benzenes; naphthalenes; ring assembly | |
flocoumafen | [no description available] | low | 0 | 0 | benzenes; naphthalenes; ring assembly | |
abt-333 | [no description available] | low | 0 | 0 | aromatic ether; naphthalenes; pyrimidone; sulfonamide | antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor |